Search bioRxiv⌕ Search

Biology subjects

Helwegen, K.

Publications and source records attributed to Helwegen, K..

2 recordsLinked to original sources

Quantifying brain connectivity signatures by means of polyconnectomic scoring

A broad range of neuropsychiatric disorders are associated with alterations in macroscale brain circuitry and connectivity. Identifying consistent brain patterns underlying these disorders by means of structural and functional MRI has proven challenging, partly due to the vast number of tests required to examine the entire brain, which can lead to an increase in missed findings. In this study, we propose polyconnectomic score (PCS) as a metric designed to quantify the presence of disease-related brain connectivity signatures in connectomes. PCS summarizes evidence of brain patterns related to a phenotype across the entire landscape of brain connectivity into a subject-level score. We evaluated PCS across four brain disorders (autism spectrum disorder, schizophrenia, attention deficit hyperactivity disorder, and Alzheimers disease) and 14 studies encompassing [~]35,000 individuals. Our findings consistently show that patients exhibit significantly higher PCS compared to controls, with effect sizes that go beyond other single MRI metrics ([min, max]: Cohens d = [0.30, 0.87], AUC = [0.58, 0.73]). We further demonstrate that PCS serves as a valuable tool for stratifying individuals, for example within the psychosis continuum, distinguishing patients with schizophrenia from their first-degree relatives (d = 0.42, p = 4 x 10-3, FDR-corrected), and first-degree relatives from healthy controls (d = 0.34, p = 0.034, FDR-corrected). We also show that PCS is useful to uncover associations between brain connectivity patterns related to neuropsychiatric disorders and mental health, psychosocial factors, and body measurements.

neuroscience↗

Reproducibility of neuroimaging studies of brain disorders with hundreds -not thousands- of participants

An important current question in neuroimaging concerns the sample sizes required for producing reliable and reproducible results. Recent findings suggest that brain-wide association studies (BWAS) linking neuroimaging features with behavioural phenotypes in the general population are characterised by (very) weak effects and consequently need large samples sizes of 3000+ to lead to reproducible findings. A second, important goal in neuroimaging is to study brain structure and function under disease conditions, where effects are likely much larger. This difference in effect size is important. We show by means of power calculations and empirical analysis that neuroimaging studies in clinical populations need hundreds -and not necessarily thousands-of participants to lead to reproducible findings.

neuroscience↗